China Shineway Pharmaceutical Group Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Shineway Pharmaceutical Group Limited with three other
companies in this sector in Hong Kong:
Dawnrays Pharmaceutical (Holdings) Ltd
sales of 1.21 billion Hong Kong Dollars [US$156.52 million]
of which 76%
was Finished Drugs),
China Grand Pharmaceutical and Healthcare Holdings Limited
(3.25 billion Hong Kong Dollars [US$418.35 million]
of which 100%
was Health Products), and
Hua Han Health Industry Holdings Ltd
(1.82 billion Hong Kong Dollars [US$234.68 million]
of which 89%
was Manufacture, sale and trading of pharmac).
During the year ended December of 2015, sales at
China Shineway Pharmaceutical Group Limited were HK$2.53 billion (US$326.52 million).
decrease of 9.6%
versus 2014, when the company's sales were HK$2.80 billion.
The sales level in 2015 was fairly close to the level five years ago: in 2010, China Shineway Pharmaceutical Group Limited had sales
of HK$2.34 billion.